# Eneura, Inc.

- Location (FDA's records): Sunnyvale, CA
- FDA decisions: 4 (2016–2023): 4 510(k) clearances
- Names in FDA's records: Eneura, Inc. (3); Eneura®, Inc. (1)
- Product codes: OKP (4)
- Predicates its devices cite: 4 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Eneura Therapeutics, LLC: 2 (https://510kreport.com/company/eneura-therapeutics)

## Its most-cited devices
- K162797: SpringTMS (2017), cited by 1
- K182976: SpringTMS (2019), cited by 1

## Recent decisions
- K230358: SAVI Dual (TM) Migraine Therapy (May 16, 2023)
- K182976: SpringTMS (Feb 25, 2019)
- K162797: SpringTMS (Jun 26, 2017)
- K161663: sTMS mini (Aug 23, 2016)

Source page: https://510kreport.com/company/eneura